Fighting cancers from within: augmenting tumor immunity with cytokine therapy
Authors:
- Marc PellegriniMPMarc Pellegrini
- Tak W. MakTMTak W. Mak
- Pamela S. OhashiPOPamela S. Ohashi
- 1 August 2010
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 31 (8) , 356-363
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- The cunning little vixen: Foxo and the cycle of life and deathNature Immunology, 2009
- IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3European Journal of Immunology, 2008
- IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinomaCancer Immunology, Immunotherapy, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15Immunity, 2007
- Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: Multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawalCytokine, 2006
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006